Analysts Say That Adc Therapeutics SA (NYSE:ADCT) Is Likely To Make It To 13 In 12 Months
In last trading session, Adc Therapeutics SA (NYSE:ADCT) saw 0.66 million shares changing hands with its beta currently measuring 1.60. Company’s recent per share price